EcoR1 Capital, LLC 13D and 13G filings for Arcus Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 5:42 pm Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 0 0.000% | -5,523,358 (Position Closed) | Filing |
| 2022-02-14 4:02 pm Purchase | 2021-12-31 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 5,523,358 7.900% | 951,311 (+20.81%) | Filing |
| 2021-07-19 5:16 pm Purchase | 2021-07-09 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 4,572,047 6.400% | 4,572,047 (New Position) | Filing |